Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology? (Q38178503)

From Wikidata
Jump to navigation Jump to search
scientific article published on 07 March 2014
edit
Language Label Description Also known as
English
Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
scientific article published on 07 March 2014

    Statements

    Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology? (English)
    Benjamin J Lamont
    Sofianos Andrikopoulos

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit